LYY

Eli Lilly ("Lilly") is a leading global pharmaceutical company with a history of nearly 150 years in drug discovery and commercialization. The company has developed numerous blockbuster medicines in diabetes care (insulin analogues), obesity treatment (tirzepatide), oncology/immuno-oncology therapies, neuroscience drugs including Alzheimer's treatments, as well as COVID‑19 monoclonal antibodies. Its clinical results have led to several FDA approvals in recent years—including innovative therapies for metabolic diseases and infectious disease emergencies—and it maintains an extensive late-stage pipeline across major therapeutic areas[3][5][2].